Relife Drugs Private Limited

Relife Drugs Private Limited - pharma in Lucknow, Uttar Pradesh, India. FY 2026 financials & compliance.
CIN U51397UP2005PTC030071 Incorporated 30 May 2005 ROC Uttar Pradesh HQ Lucknow, Uttar Pradesh, India
Active Private Limited Company pharma
Revenue · FY 2025
₹1.55 Cr
▲ 21% YoY
Net profit · FY 2025
₹1.81 Lakh
Net margin 1.2%
EBITDA · FY 2025
₹2.44 Lakh
EBITDA margin 1.6%
Authorised capital
₹2 Lakh
Registered with MCA
Paid-up capital
₹1.5 Lakh
Issued & subscribed
Company age
21 yrs
Est. 2005
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered

About Relife Drugs Private Limited

Data last updated:

Relife Drugs Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 30 May 2005 and has been in existence for over 21 years.

The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U51397UP2005PTC030071. Its GSTIN is 09AADCR0119B1ZY (Uttar Pradesh).

The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1.5 Lakh. It is led by directors including Madhuri Sharma and Asif Ikbal Khan.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at S – 301 Phase – 1st Transport Nagar, Lucknow, Uttar Pradesh, India – 226012.

As per the financials filed for FY 2025, the company reported a revenue of ₹1.55 Cr, a growth of 21% compared to the previous year. For the same year it recorded a net profit of ₹1.81 Lakh (net margin 1.2%) and EBITDA of ₹2.44 Lakh (EBITDA margin 1.6%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 5% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U51397UP2005PTC030071
Registration Number 030071
Incorporation Date 30 May 2005
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Relife Drugs Private Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    S – 301 Phase – 1st Transport Nagar, Lucknow, Uttar Pradesh, India – 226012
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Relife Drugs Private Limited, buy the company report.

Comprehensive company report
Relife Drugs Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Relife Drugs is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Relife Drugs Private Limited, buy the company report.

Financials of Relife Drugs Private Limited

FY 2025 filings available

Relife Drugs Private Limited reported revenue of ₹1.55 Cr (up 21% YoY) for FY 2025.

Revenue · FY 2025
₹1.55 Cr ▲ 21%
Net profit · FY 2025
₹1.81 Lakh margin 1.2%
EBITDA · FY 2025
₹2.44 Lakh margin 1.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 21%
3 years · compounded
▲ 12%
5 years · compounded
▲ 5%
EBITDA CAGR growth
1 year
▲ 26%
3 years · compounded
▲ 12%

Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 21% growth in the latest year. EBITDA rose 26% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2.44 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.81 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin1.6%
Net Profit Margin1.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Relife Drugs Private Limited, buy the company report.

Board of directors of Relife Drugs Private Limited

Relife Drugs has 3 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Madhuri SharmaDirector30 May 200521 Years 5 MonthsCurrent
Asif Ikbal KhanDirector30 May 200521 Years 5 MonthsCurrent
Ravi Praksh SharmaDirector30 May 200521 Years 5 MonthsCurrent

Peer comparison

Relife Drugs Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Amstel Pharma Private Limited₹1.56 Cr (FY 2024)20.0%Thrissur, Kerala, India
Asteroids Healthcare Private Limited₹1.56 Cr (FY 2024)5.0%Jaipur, Rajasthan, India
Relife Drugs Private Limitedthis company₹1.55 Cr (FY 2025)₹1.81 Lakh1.2%21.0%Lucknow, Uttar Pradesh, India
Maximon Pharma Private Limited₹1.55 Cr (FY 2025)30.0%New Delhi, Delhi, India
Inowell Pharma Private Limited₹1.55 Cr (FY 2025)33.0%Indore, Madhya Pradesh, India

To see the full peer comparison of Relife Drugs Private Limited, buy the company report.

Auditor

Relife Drugs Private Limited is audited by ARUN K RASTOGI & CO for the financial year 2017.

Auditor firmFinancial yearFirm registration number
ARUN K RASTOGI & COFY 2017004265C

Shareholding

The shareholding of Relife Drugs Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Relife Drugs Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Relife Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Relife Drugs has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
09AADCR0119B1ZYUttar PradeshActive23 Mar 2021

To see the full GST registrations and return filing status of Relife Drugs Private Limited, buy the company report.

Recent activity

Relife Drugs Private Limited has 3 board changes on record since 2005: 3 appointments. The latest: Asif Ikbal Khan was appointed as Director on 30 May 2005.

AGM
Relife Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Relife Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh I.
Appointed
Asif Ikbal Khan was appointed as Director.
Appointed
Madhuri Sharma was appointed as Director.
Appointed
Ravi Praksh Sharma was appointed as Director.
Incorporation
30 May 2005
Relife Drugs Private Limited was registered on 30 May 2005 with Roc Uttar Pradesh I & aged 21 years 5 months as per MCA records.

Frequently asked questions

Relife Drugs is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 30 May 2005 (21+ years old) and is registered under CIN U51397UP2005PTC030071.

Relife Drugs has 3 current directors:

The latest financial statements of Relife Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Relife Drugs is 09AADCR0119B1ZY, registered in Uttar Pradesh.

The CIN (Corporate Identification Number) of Relife Drugs is U51397UP2005PTC030071. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Relife Drugs was incorporated on 30 May 2005, making it 21+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.

The peers of Relife Drugs by revenue are Amstel Pharma Private Limited, Asteroids Healthcare Private Limited, Maximon Pharma Private Limited, Inowell Pharma Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).

Asif Ikbal Khan was appointed as Director on 30 May 2005. Madhuri Sharma was appointed as Director on 30 May 2005. Ravi Praksh Sharma was appointed as Director on 30 May 2005.

The registered office of Relife Drugs is at S – 301 Phase – 1st Transport Nagar, Lucknow, Uttar Pradesh, India – 226012.

Relife Drugs operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

The compliance status of Relife Drugs is compliant as of 19 September 2026. The company is actively filing with the Registrar of Companies.